Jonathan Violin is the Chief Executive Officer of Viridian Therapeutics, a biotechnology company focused on developing treatments for rare diseases.
Jonathan Violin is the Chief Executive Officer of Viridian Therapeutics, a biotechnology company focused on developing treatments for rare diseases. He has raised over $1 billion in capital for public and private biotech companies throughout his career.
Full founder directory · Investor directory · Company funding database · Fundraising library